Japan Medical Dynamic Marketing, Inc. (7600) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shofu, Inc.

Rion Co., Ltd.

Mizuho Medy Co., Ltd.

Jins Holdings, Inc.

CYBERDYNE, Inc.

FRANCE BED HOLDINGS CO., LTD.

Medikit Co., Ltd.

Japan Medical Dynamic Marketing, Inc.

Eiken Chemical Co., Ltd.

Seed Co., Ltd. /7743/

ReproCELL, Inc.

Why is Japan Medical Dynamic Marketing, Inc. ?

Poor long term growth as Operating profit has grown by an annual rate -17.16% of over the last 5 years

With a fall in Net Sales of -5.23%, the company declared Very Negative results in Mar 26

The company has declared negative results for the last 8 consecutive quarters
INTEREST(HY) At JPY 109.08 MM has Grown at 113.04%
PRE-TAX PROFIT(Q) At JPY 49.24 MM has Fallen at -72.91%
INTEREST COVERAGE RATIO(Q) Lowest at 850.81

Underperformed the market in the last 1 year

The stock has generated a return of 64.83% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 85.83%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Japan Medical Dynamic Marketing, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Japan Medical Dynamic Marketing, Inc.

60.7%

0.83

56.88%

Japan Nikkei 225

85.83%

3.09

27.80%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.80%

EBIT Growth (5y)

-17.16%

EBIT to Interest (avg)

50.24

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.86

Tax Ratio

36.99%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

9.34%

ROE (avg)

7.30%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.60

EV to EBIT

21.11

EV to EBITDA

7.27

EV to Capital Employed

0.64

EV to Sales

0.73

PEG Ratio

Dividend Yield

ROCE (Latest)

3.02%

ROE (Latest)

2.84%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

DIVIDEND PER SHARE(HY)

Highest at JPY 4.21

CASH AND EQV(HY)

Highest at JPY 5,588.46 MM

-29What is not working for the Company

INTEREST(HY)

At JPY 109.08 MM has Grown at 113.04%

PRE-TAX PROFIT(Q)

At JPY 49.24 MM has Fallen at -72.91%

INTEREST COVERAGE RATIO(Q)

Lowest at 850.81

RAW MATERIAL COST(Y)

Grown by 7.57% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 10.88 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.74 times

OPERATING PROFIT MARGIN(Q)

Lowest at 7.91 %

NET PROFIT(Q)

Lowest at JPY -24.12 MM

Here's what is working for Japan Medical Dynamic Marketing, Inc.

Dividend per share

Highest at JPY 4.21 and Grown

In each year in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (JPY)

Cash and Eqv

Highest at JPY 5,588.46 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Depreciation

Highest at JPY 417.6 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for Japan Medical Dynamic Marketing, Inc.

Interest

At JPY 109.08 MM has Grown at 113.04%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Pre-Tax Profit

At JPY 49.24 MM has Fallen at -72.91%

over average net sales of the previous four periods of JPY 181.77 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Net Profit

At JPY -24.12 MM has Fallen at -113.23%

over average net sales of the previous four periods of JPY 182.3 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (JPY MM)

Interest Coverage Ratio

Lowest at 850.81

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit Margin

Lowest at 7.91 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Net Profit

Lowest at JPY -24.12 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (JPY MM)

Debt-Equity Ratio

Highest at 10.88 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 0.74 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 7.57% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales